Are anorexia nervosa and bulimia nervosa separate disorders? challenging the 'transdiagnostic' theory of eating disorders

European Eating Disorders Review

Volumn 17, Issue 1, 2009, Pages 2-13

  Birmingham, C Laird ^a,b   Touyz, Stephen ^c   Harbottle, Jane ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anorexia nervosa; Bulimia nervosa; Classification; Diagnosis; Transdiagnostic theory

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; OLANZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ANALOGY; ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANOREXIA NERVOSA; ARTICLE; BINGE EATING DISORDER; BIOLOGICAL GRADIENT; BULIMIA; CAUSAL ATTRIBUTION; CLINICAL TRIAL; COGNITIVE THERAPY; COHERENCE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG RESPONSE; EATING DISORDER; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; GENETIC ASSOCIATION; GENETIC EPISTASIS; HILL CRITERIA OF CAUSATION; HUMAN; INTERNAL CONSISTENCY; NEUROIMAGING; NONHUMAN; PLAUSIBILITY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL THEORY; PSYCHOTHERAPY; SENSITIVITY AND SPECIFICITY; TRANSDIAGNOSTIC THEORY; VOMITING; WEIGHT GAIN; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; INCIDENCE; MORTALITY; ONSET AGE; REPRODUCIBILITY; REVIEW; SURVIVAL RATE;

AGE OF ONSET; ANOREXIA NERVOSA; BULIMIA NERVOSA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INCIDENCE; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE;

EID: 65849142419     PISSN: 10724133     EISSN: 10990968     Source Type: Journal    
DOI: 10.1002/erv.896     Document Type: Article

References (93)

1. American Psychiatric Association. (2004). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press.
2. Audenaert, K., Van Laere, K., Dumont, F., Vervaet, M., Goethals, I., Slegers, G., et al. (2003). Decreased 5-ht2a receptor binding in patients with anorexia nervosa. Journal of Nuclear Medicine, 44, 163-169.
3. Bacanu, S. A., Bulik, C. M., Klump, K. L., Fichter, M. M., Halmi, K. A., Keel, P., et al. (2005). Linkage analysis of anorexia and bulimia nervosa cohorts using selected behavioral phenotypes as quantitative traits or covariates. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 139, 61-68.
4. Bailer, U. F., Price, J. C., Meltzer, C. C., Mathis, C. A., Frank, G. K., Weissfeld, L., et al. (2004). Altered 5-ht(2a) receptor binding after recovery from bulimia-type anorexia nervosa: Relationships to harm avoidance and drive for thinness. Neuropsychopharmacology, 29, 1143-1155.
5. Barnes, N. M., & Sharp, T. (1999). A review of central 5-ht receptors and their function. Neuropharmacology, 38, 1083-1152.
6. Beumont, P. J. V., & Touyz, S. W. (2003). What kind of illness is anorexia nervosa? European Child & Adolescent Psychiatry, 12, 65-71.
7. Birmingham, C. L., & Beumont, P. (2004). Medical management of eating disorders: A practical handbook for healthcare professionals. Cambridge, UK: Cambridge University Press.
8. Birmingham, C. L., Gutierrez, E., Jonat, L., & Beumont, P. (2004). Randomized controlled trial of warming in anorexia nervosa. International Journal of Eating Disorders, 35, 234-238.
9. Birmingham, C. L., Su, J., Hlynsky, J. A., Goldner, E. M., & Gao, M. (2005). The mortality rate from anorexia nervosa. International Journal of Eating Disorders, 38, 143-146.
10. Braga, R. J., Mendlowicz, M. V., Marrocos, R. P., & Figueira, I. L. (2005). Anxiety disorders in outpatients with schizophrenia: Prevalence and impact on the subjective quality of life. Journal of Psychiatric Research, 39, 409-414.
11. Brust, J. C. M. (2004). Neurological aspects of substance abuse (2nd ed.). Philadelphia, PA: Elsevier. (First edition published in 1993).
12. Bulik, C. M. (1987). Drug and alcohol abuse by bulimic women and their families. American Journal of Psychiatry, 144, 1604-1606.
13. Bulik, C. M., Devlin, B., Bacanu, S. A., Thornton, L., Klump, K. L., Fichter, M. M., et al. (2003). Significant linkage on chromosome 10p in families with bulimia nervosa. American Journal of Human Genetics, 72, 200-207.
14. Bulik, C. M., Sullivan, P. F., Carter, F. A., & Joyce, P. R. (1997a). Lifetime comorbidity of alcohol dependence in women with bulimia nervosa. Addictive Behaviors, 22, 437-446.
15. Bulik, C. M., Sullivan, P. F., Fear, J., & Pickering, A. (1997b). Predictors of the development of bulimia nervosa in women with anorexia nervosa. Journal of Nervous and Mental Disease, 185, 704-707.
16. Carrera, O., Gutierrez, E., & Boakes, R. A. (2006). Early handling reduces vulnerability of rats to activity-based anorexia. Developmental Psychobiology, 48, 520-527.
17. Connan, F., Murphy, F., Connor, S. E., Rich, P., Murphy, T., Bara-Carill, N., et al. (2006). Hippocampal volume and cognitive function in anorexia nervosa. Psychiatry Research, 146, 117-125.
18. Corcos, M., Nezelof, S., Speranza, M., Topa, S., Girardon, N., Guilbaud, O., et al. (2001). Psychoactive substance consumption in eating disorders. Eating Behaviors, 2, 27-38.
19. Crabbe, J. C., Phillips, T. J., Buck, K. J., Cunningham, C. L., & Belknap, J. K. (1999). Identifying genes for alcohol and drug sensitivity: Recent progress and future directions. Trends in Neurosciences, 22, 173-179.
20. Currin, L., Schmidt, U., Treasure, J., & Jick, H. (2005). Time trends in eating disorder incidence. British Journal of Psychiatry, 186, 132-135.
21. Dansky, B. S., Brewerton, T. D., & Kilpatrick, D. G. (2000). Comorbidity of bulimia nervosa and alcohol use disorders: Results from the national women's study. International Journal of Eating Disorders, 27, 180-190.
22. Delvenne, V., Lotstra, F., Goldman, S., Biver, F., De Maertelaer, V., Appelboom-Fondu, J., et al. (1995). Brain hypometabolism of glucose in anorexia nervosa: A pet scan study. Biological Psychiatry, 37, 161-169.
23. Devlin, B., Bacanu, S. A., Klump, K. L., Bulik, C. M., Fichter, M. M., Halmi, K. A., et al. (2002). Linkage analysis of anorexia nervosa incorporating behavioral covariates. Human Molecular Genetics, 11, 689-696.
24. Eckert, E. D., Halmi, K. A., Marchi, P., Grove, W., & Crosby, R. (1995). Ten-year follow-up of anorexia nervosa: Clinical course and outcome. Psychological Medicine, 25, 143-156.
25. Eddy, K. T., Dorer, D. J., Franko, D. L., Tahilani, K., Thompson-Brenner, H., & Herzog, D. B. (2007). Should bulimia nervosa be subtyped by history of anorexia nervosa? A longitudinal validation. International Journal of Eating Disorders, 40, S67-S71.
26. Eddy, K. T., Keel, P. K., Dorer, D. J., Delinsky, S. S., Franko, D. L., & Herzog, D. B. (2002). Longitudinal comparison of anorexia nervosa subtypes. International Journal of Eating Disorders, 31, 191-201.
27. Fairburn, C. G., & Bohn, K. (2005). Eating disorder NOS (EDNOS): An example of the troublesome "not otherwise specified" (NOS) category in DSM-IV. Behaviour Research and Therapy, 43, 691-701.
28. Fairburn, C. G., & Cooper, Z., & Shafran, R. (2003). Cognitive behaviour therapy for eating disorders: A "transdiagnostic" theory and treatment. Behavior Research and Therapy, 41, 509-528.
29. Fairburn, C. G., & Harrison, P. J. (2003). Eating disorders. Lancet, 361, 407-416.
30. Fennig, S., Kovasznay, B., Rich, C., Ram, R., Pato, C., Miller, A., et al. (1994). Six-month stability of psychiatric diagnoses in first-admission patients with psychosis. American Journal of Psychiatry, 151, 1200-1208.
31. Ferguson, C. P., La Via, M. C., Crossan, P. J., & Kaye, W. H. (1999). Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?International Journal of Eating Disorders, 25, 11-17.
32. Fichter, M. M., Leibl, K., Rief, W., Brunner, E., Schmidt-Auberger, S., & Engel, R. R. (1991). Fluoxetine versus placebo: A double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry, 24, 1-7.
33. Fichter, M. M., & Quadflieg, N. (2004). Twelve-year course and outcome of bulimia nervosa. Psychological Medicine, 34, 1395-1406.
34. First, M. B., Pincus, H. A., Levine, J. B., Williams, J. B., Ustun, B., & Peele, R. (2004). Clinical utility as a criterion for revising psychiatric diagnoses. American Journal of Psychiatry, 161, 946-954.
35. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine bulimia nervosa collaborative study group. (1992). Archives of General Psychiatry, 49, 139-147.
36. Frank, G. K., Kaye, W. H., Meltzer, C. C., Price, J. C., Greer, P., McConaha, C., et al. (2002). Reduced 5-ht2a receptor binding after recovery from anorexia nervosa. Biological Psychiatry, 52, 896-906.
37. Giordano, G. D., Renzetti, P., Parodi, R. C., Foppiani, L., Zandrino, F., Giordano, G., et al. (2001). Volume measurement with magnetic resonance imaging of hippocampus-amygdala formation in patients with anorexia nervosa. Journal of Endocrinological Investigation, 24, 510-514.
38. Goldstein, D. J., Wilson, M. G., Thompson, V. L., Potvin, J. H., & Rampey, A. H. Jr., (1995). Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine bulimia nervosa research group. British Journal of Psychiatry, 166, 660-666.
39. Goodman, A. (2007). Neurobiology of addiction an integrative review. Biochemical Pharmacology, 75, 266-322.
40. Grice, D. E., Halmi, K. A., Fichter, M. M., Strober, M., Woodside, D. B., Treasure, J. T., et al. (2002). Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. American Journal of Human Genetics, 70, 787-792.
41. Hay, P., & Fairburn, C. (1998). The validity of the DSM-IV scheme for classifying bulimic eating disorders. International Journal of Eating Disorders, 23, 7-15.
42. Hay, P. J., & Bacaltchuk, J. (2003). Psychotherapy for bulimia nervosa and binging. Cochrane Database of Systematic Reviews, CD000562.
43. Hay, P. J., Bacaltchuk, J., & Stefano, S. (2004). Psychotherapy for bulimia nervosa and binging. Cochrane Database of Systematic Reviews, CD000562.
44. Herzog, D. B., Franko, D. L., Dorer, D. J., Keel, P. K., Jackson, S., & Manzo, M. P. (2006). Drug abuse in women with eating disorders. International Journal of Eating Disorders, 39, 364-368.
45. Hill, A. B. (1965). The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, 58, 295-300.
46. Hiller, W., Dichtl, G., Hecht, H., Hundt, W., & von Zerssen, D. (1993). An empirical comparison of diagnoses and reliabilities in ICD-10 and DSM-III-R. European Archives of Psychiatry and Clinical Neuroscience, 242, 209-217.
47. Hoek, H. W., van Harten, P. N., Hermans, K. M., Katzman, M. A., Matroos, G. E., & Susser, E. S. (2005). The incidence of anorexia nervosa on curacao. American Journal of Psychiatry, 162, 748-752.
48. Holderness, C. C., Brooks-Gunn, J., & Warren, M. P. (1994). Co-morbidity of eating disorders and substance abuse review of the literature. International Journal of Eating Disorders, 16, 1-34.
49. Jones, D. A., Cheshire, N., & Moorhouse, H. (1985). Anorexia nervosa, bulimia and alcoholism-association of eating disorder and alcohol. Journal of Psychiatric Research, 19, 377-380.
50. Katzman, D. K., Lambe, E. K., Mikulis, D. J., Ridgley, J. N., Goldbloom, D. S., & Zipursky, R. B. (1996). Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. Journal of Pediatrics, 129, 794-803.
51. Kaye, W. H., Frank, G. K., Bailer, U. F., Henry, S. E., Meltzer, C. C., Price, J. C., et al. (2005). Serotonin alterations in anorexia and bulimia nervosa: New insights from imaging studies. Physiology & Behavior, 85, 73-81.
52. Kaye, W. H., Nagata, T., Weltzin, T. E., Hsu, L. K., Sokol, M. S., McConaha, C., et al. (2001). Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biological Psychiatry, 49, 644-652.
53. Keltikangas-Jarvinen, L., Puttonen, S., Kivimaki, M., Elovainio, M., Pulkki-Raback, L., Koivu, M., et al. (2007). Serotonin receptor genes 5ht1a and 5ht2a modify the relation between childhood temperament and adulthood hostility. Genes Brain and Behavior, 7, 46-52.
54. Krieg, J. C., Lauer, C., Leinsinger, G., Pahl, J., Schreiber, W., & Pirke, K. M., et al. (1989). Brain morphology and regional cerebral blood flow in anorexia nervosa. Biological Psychiatry, 25, 1041-1048.
55. Lacey, J. H. (1993). Self-damaging and addictive behaviour in bulimia nervosa. A. Catchment area study. British Journal of Psychiatry, 163, 190-194.
56. Lilenfeld, L. R., Kaye, W. H., Greeno, C. G., Merikangas, K. R., Plotnicov, K., Pollice, C., et al. (1998). A controlled family study of anorexia nervosa and bulimia nervosa: Psychiatric disorders in first-degree relatives and effects of proband comorbidity. Archives of General Psychiatry, 55, 603-610.
57. Maclure, M. (1985). Popperian refutation in epidemiology. American Journal of Epidemiology, 121, 343-350.
58. Maguire, S., Le Grange, D., Surgenor, L., Marks, P., Lacey, H., & Touyz, J. (2008). Staging anorexia nervosa: Conceptualising illness severity. Early Intervention in Psychiatry, 2, 3-10.
59. McElroy, S. L., Altshuler, L. L., Suppes, T., Keck, P. E., Jr., Frye, M. A., Denicoff, K. D., et al. (2001). Axis i psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. American Journal of Psychiatry, 158, 420-426.
60. McIntosh, V.V., Jordan, J., Carter, F. A., Luty, S. E., McKenzie, J. M., Bulik, C. M., et al. (2005). Three psychotherapies for anorexia nervosa: A randomized, controlled trial. American Journal of Psychiatry, 162, 741-747.
61. Milano, W., Siano, C., Putrella, C., & Capasso, A. (2005). Treatment of bulimia nervosa with fluvoxamine: A randomized controlled trial. Advances in Therapy, 22, 278-283.
62. Mitchell, J. E., Hatsukami, D., Eckert, E. D., & Pyle, R. L. (1985). Characteristics of 275 patients with bulimia. American Journal of Psychiatry, 142, 482-485.
63. Mitchell, J. E., Specker, S. M., & de Zwaan, M. (1991). Comorbidity and medical complications of bulimia nervosa. Journal of Clinical Psychiatry, 52, S13-S20.
64. Mondraty, N., Birmingham, C. L., Touyz, S., Sundakov, V., Chapman, L., & Beumont, P. (2005). Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australasian Psychiatry, 13, 72-75.
65. Nielsen, S., & Palmer, B. (2003). Diagnosing eating disorders - AN, BN and the others. Acta Psychiatrica Scandinavica, 108, 161-162.
66. Paykel, E. S., Hayhurst, H., Abbott, R., & Wadsworth, M. (2001). Stability and change in milder psychiatric disorder over 7 years in a birth cohort. Psychological Medicine, 31, 1373-1384.
67. Perez, M., Hernandez, A., Clarke, A., & Joiner, T. E. Jr., (2007). Analysis of bulimic symptomatology across age and geographic locations. Eating Behaviors, 8, 136-142.
68. Pike, K. M., Walsh, B. T., Vitousek, K., Wilson, G. T., & Bauer, J. (2003). Cognitive behavior therapy in the post-hospitalization treatment of anorexia nervosa. American Journal of Psychiatry, 160, 2046-2049.
69. Rankinen, T., & Bouchard, C. (2006). Genetics of food intake and eating behavior phenotypes in humans. Annual Review of Nutrition, 26, 413-434.
70. Romano, S. J., Halmi, K. A., Sarkar, N. P., Koke, S. C., & Lee, J. S. (2002). A. placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. American Journal of Psychiatry, 159, 96-102.
71. Rothman, K. J., & Greenland, S. (2005). Causation and causal inference in epidemiology. American Journal of Public Health, 95, S144-S150.
72. Rounsaville, B. J. (2002). Experience with ICD-10/DSM-IV substance use disorders. Psychopathology, 35, 82-88.
73. Santonastaso, P., Zanetti, T., De Antoni, C., Tenconi, E., & Favaro, A. (2006). Anorexia nervosa patients with a prior history of bulimia nervosa. Comprehensive Psychiatry, 47, 519-522.
74. Schwartz, J. E., Fennig, S., Tanenberg-Karant, M., Carlson, G., Craig, T., Galambos, N., et al. (2000). Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Archives of General Psychiatry, 57, 593-600.
75. Seeger, G., Braus, D. F., Ruf, M., Goldberger, U., & Schmidt, M. H. (2002). Body image distortion reveals amygdala activation in patients with anorexia nervosa - a functional magnetic resonance imaging study. Neuroscience Letters, 326, 25-28.
76. Simon, N. M., Otto, M. W., Wisniewski, S. R., Fossey, M., Sagduyu, K., Frank, E., et al. (2004). Anxiety disorder comorbidity in bipolar disorder patients: Data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder (step-bd). American Journal of Psychiatry, 161, 2222-2229.
77. Stamatakis, E. A., & Hetherington, M. M. (2003). Neuroimaging in eating disorders. Nutritional Neuroscience, 6, 325-334.
78. Strober, M., Freeman, R., & Morrell, W. (1997). The longterm course of severe anorexia nervosa in adolescents: Survival analysis of recovery, relapse, and outcome predictors over10-15years in a prospective study. International Journal of Eating Disorders, 22, 339-360.
79. Sullivan, P. F., Bulik, C. M., Carter, F. A., Gendall, K. A., & Joyce, P. R. (1996). The significance of a prior history of anorexia in bulimia nervosa. International Journal of Eating Disorders, 20, 253-261.
80. Swayze, V. W. 2nd, Andersen, A. E., Andreasen, N. C., Arndt, S., Sato, Y., & Ziebell, S. (2003). Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. International Journal of Eating Disorders, 33, 33-44.
81. Taiminen, T., Ranta, K., Karlsson, H., Lauerma, H., Leinonen, K. M., Wallenius, E., et al. (2001). Comparison of clinical and best-estimate research DSM-IV diagnoses in a finnish sample of first-admission psychosis and severe affective disorder. Nordic Journal of Psychiatry, 55, 107-111.
82. Tozzi, F., Thornton, L. M., Klump, K. L., Fichter, M. M., Halmi, K. A., Kaplan, A. S., et al. (2005). Symptom fluctuation in eating disorders: Correlates of diagnostic crossover. American Journal of Psychiatry, 162, 732-740.
83. Treasure, J. L. & Owen, J. B. (1997). Intriguing links between animal behavior and anorexia nervosa. International Journal of Eating Disorder, 21, 307-311.
84. Uher, R., Murphy, T., Friederich, H. C., Dalgleish, T., Brammer, M. J., Giampietro, V., et al. (2005). Functional neuroanatomy of body shape perception in healthy and eating-disordered women. Biological Psychiatry, 58, 990-997.
85. Urwin, R. E., Bennetts, B., Wilcken, B., Lampropoulos, B., Beumont, P., Clarke, S., et al. (2002). Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region. Molecular Psychiatry, 7, 652-657.
86. Urwin, R. E., Bennetts, B. H., Wilcken, B., Lampropoulos, B., Beumont, P. J., Russell, J. D., et al. (2003). Gene-gene interaction between the monoamine oxidase a gene and solute carrier family 6 (neurotransmitter transporter, noradrenalin) member 2 gene in anorexia nervosa (restrictive subtype). European Journal of Human Genetics, 11, 945-950.
87. Urwin, R. E., & Nunn, K. P. (2005). Epistatic interaction between the monoamine oxidase a and serotonin transporter genes in anorexia nervosa. European Journal of Human Genetics, 13, 370-375.
88. Vazquez, R., Carrera, O., Birmingham, L., & Gutierrez, E. (2006). Exploring the association between anorexia nervosa and geographical latitude. Eating and Weight Disorders, 11, 1-8.
89. Wade, T. D., Bergin, J. L., Martin, N. G., Gillespie, N. A., & Fairburn, C. G. (2006). A. transdiagnostic approach to understanding eating disorders. Journal of Nervous and Mental Disease, 194, 510-517.
90. Walsh, B. T., Kaplan, A. S., Attia, E., Olmsted, M., Parides, M., Carter, J. C., et al. (2006). Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial. JAMA, 295, 2605-2612.
91. Welch, S. L., & Fairburn, C. G. (1996). Impulsivity or comorbidity in bulimia nervosa. A. Controlled study of deliberate self-harm and alcohol and drug misuse in a community sample. British Journal of Psychiatry, 169, 451-458.
92. White, V. O., & Gardner, J. M. (2002). Presence of anorexia nervosa and bulimia nervosa in Jamaica. West Indian Medical Journal, 51, 32-34.
93. Wilson, J. R. (1992). Bulimia nervosa: Occurrence with psychoactive substance use disorders. Addictive Behaviors, 17, 603-607.